Apolipoprotein C3 is Downregulated in Patients with Inflammatory Bowel Disease

被引：0
|
作者：
Camba, A. Hernandez [1 ]
Palau, M. Carrillo [2 ]
Ramos, L. [2 ]
Alonso, I. [2 ]
Vela, M. [1 ]
Hernandez, A. [2 ]
Arranz, L. [1 ]
Hernandez, N. [2 ]
Hernandez-Guerra, M. [2 ]
Ferraz, I. [3 ]
机构：
[1] Hosp Univ Nuestra Senora Candelaria, Dept Gastroenterol, Santa Cruz De Tenerife, Spain
[2] Hosp Univ Canarias, Gastroenterol, San Cristobal la Laguna, Spain
[3] Hosp Univ Canarias, Reumatol, San Cristobal la Laguna, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P485
引用
收藏
页码：I451 / I452
页数：2
相关论文
共 50 条
  • [1] Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease
    Hernandez-Camba, Alejandro
    Carrillo-Palau, Marta
    Ramos, Laura
    de Armas-Rillo, Laura
    Vela, Milagros
    Arranz, Laura
    Gonzalez-Gay, Miguel A.
    Ferraz-Amaro, Ivan
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2022, 13 (06) : E00500
  • [2] Apolipoprotein C3 is Downregulated in Patients with Inflammatory Bowel Disease
    Hernandez Camba, A.
    Carrillo Palau, M.
    Ramos, L.
    Alonso, I.
    Vela, M.
    Hernandez, A.
    Arranz, L.
    Hernandez, N.
    Hernandez-Guerra, M.
    Ferraz, I.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I451 - I452
  • [3] Identification of complement C3 as an autoantigen in inflammatory bowel disease
    Lundgren, Brita Ardesjo
    Rorsman, Fredrik
    Portela-Gomes, Guida M.
    Grimelius, Lars
    Ekdahl, Kristina Nilsson
    Nilsson, Bo
    Ekwall, Olov
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (04) : 429 - 436
  • [4] EPITHELIAL PURINERGIC RECEPTORS ARE DOWNREGULATED IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Tingler, Anna
    Packirisamy, Charulekha
    Engevik, Kristen
    INFLAMMATORY BOWEL DISEASES, 2025, 31 : S46 - S46
  • [5] SERUM COMPLEMENT COMPONENTS C3 AND C4 IN INFLAMMATORY BOWEL-DISEASE
    WARD, M
    EASTWOOD, MA
    GUT, 1974, 15 (10) : 835 - 835
  • [6] Serum complement C3 and α2-macroglobulin are potentially useful biomarkers for inflammatory bowel disease patients
    Okada, Kohki
    Itoh, Hiroshi
    Ikemoto, Masaki
    HELIYON, 2021, 7 (03)
  • [7] Apolipoprotein C3 Gene Polymorphism in Nonalcoholic Fatty Liver Disease-To Be or Not To Be Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease
    Petersen, K. F.
    Dufour, S.
    Hariri, A.
    Nelson-Williams, C.
    Foo, J. N.
    Zhang, X. M.
    Dziura, J.
    Lifton, R. P.
    Shulman, G., I
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2011, 1 (01) : 51 - 52
  • [8] Apolipoprotein C3 and Cardiovascular Disease in Patients with Type 1 Diabetes and Diabetic Nephropathy
    Stechemesser, Lars
    Forsblom, Carol
    Weitgasser, Raimund
    Groop, Per-Henrik
    DIABETES, 2018, 67
  • [9] Regulation of epithelial cell expressed C3 in the intestine - Relevance for the pathophysiology of inflammatory bowel disease?
    Suenderhauf, Annika
    Skibbe, Kerstin
    Preisker, Sophie
    Ebbert, Karen
    Verschoor, Admar
    Karsten, Christian M.
    Kemper, Claudia
    Huber-Lang, Markus
    Basic, Marijana
    Bleich, Andre
    Buening, Juergen
    Fellermann, Klaus
    Sina, Christian
    Derer, Stefanie
    MOLECULAR IMMUNOLOGY, 2017, 90 : 227 - 238
  • [10] Aerobic Exercise reduces triglycerides by targeting Apolipoprotein C3 in Patients with Coronary Artery Disease
    Wang, Yating
    Xu, Danyan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C238 - C238
12345